Lung cancer survivors at high risk for recurrence, new lung cancer
the ONA take:
According to a new study presented at the American Thoracic Society (ATS) 2015 International Conference in Denver, Colorado, researchers have found that many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
For the study, researchers identified 192 lung cancer survivors who underwent surveillance for an average duration of about 8.5 years. Results showed that 38% of patients had developed recurrence or a new lung cancer during this period.
Researchers also found that for every additional pack of cigarettes smoked per year, patients had a 1% increased risk for developing lung cancer again. Other significant risk factors included presence of a nodule on a CT chest scan, premalignant lesions on three autofluorescence bronchoscopy exams anywhere in the central airway, and having recurrence of another non-lung cancer.
"We looked closely at risk factors that may help in predicting cancer recurrence in lung cancer survivors," said study lead author Samjot Dhillon, MD. "What we learned is that patients with a history of lung cancer should have close long-term surveillance so their doctor can detect early on if the cancer is recurring or if there is another cancer developing."
Many lung cancer survivors are at high risk for developing recurrence of their disease or developing another another lung cancer.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|